Neocrema Adds Contract Development of Active Pharmaceutical Ingredients and New Drug Development as Business Objectives

[Asia Economy Reporter Hwang Yoon-joo] Neocrema held an extraordinary general meeting of shareholders and announced on the 7th that it has added ▲contract development and manufacturing of active pharmaceutical ingredients ▲new drug development and sales ▲development and sales of obesity vaccines to its business objectives.

The company stated, "We have changed our business objectives to diversify our business."